148 related articles for article (PubMed ID: 2873245)
1. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
[TBL] [Abstract][Full Text] [Related]
3. [Effect of 5-aminosalicylic acid as a constituent of sulfasalazine in the treatment of chronic polyarthritis].
Wörth WD; Müller W
Z Rheumatol; 1986; 45(2):79-82. PubMed ID: 2873695
[TBL] [Abstract][Full Text] [Related]
4. Which component of sulphasalazine is active in rheumatoid arthritis?
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
[TBL] [Abstract][Full Text] [Related]
5. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
Symmons DP; Salmon M; Farr M; Bacon PA
J Rheumatol; 1988 Apr; 15(4):575-9. PubMed ID: 2899645
[TBL] [Abstract][Full Text] [Related]
6. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
[TBL] [Abstract][Full Text] [Related]
7. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
Martin L; Sitar DS; Chalmers IM; Hunter T
J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
[TBL] [Abstract][Full Text] [Related]
8. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA
Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
[TBL] [Abstract][Full Text] [Related]
9. Sulphasalazine in the treatment of rheumatoid arthritis.
Pelísková Z; Vácha J; Trnavský K
Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
[TBL] [Abstract][Full Text] [Related]
10. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
Volin MV; Harlow LA; Woods JM; Campbell PL; Amin MA; Tokuhira M; Koch AE
Arthritis Rheum; 1999 Sep; 42(9):1927-35. PubMed ID: 10513809
[TBL] [Abstract][Full Text] [Related]
11. Treatment of spondyloarthropathy with 5-aminosalicylic acid (mesalazine): an open trial.
Dekker-Saeys BJ; Dijkmans BA; Tytgat GN
J Rheumatol; 2000 Mar; 27(3):723-6. PubMed ID: 10743816
[TBL] [Abstract][Full Text] [Related]
12. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y
Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
[TBL] [Abstract][Full Text] [Related]
13. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
Comer SS; Jasin HE
J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
[TBL] [Abstract][Full Text] [Related]
14. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of stress-induced gastric ulcers by sulphasalazine and its constituents (sulphapyridine and 5-aminosalicylic acid) in rats.
Garg GP; Cho CH; Ogle CW
Pharmacology; 1990; 40(6):318-24. PubMed ID: 1978355
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
[TBL] [Abstract][Full Text] [Related]
17. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.
van Hees PA; Bakker JH; van Tongeren JH
Gut; 1980 Jul; 21(7):632-5. PubMed ID: 6107263
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis: is serum vitamin B12 high in active disease?
Grindulis KA; Calverley M; Cox C
J Rheumatol; 1984 Apr; 11(2):211-2. PubMed ID: 6144796
[TBL] [Abstract][Full Text] [Related]
19. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
van Riel PL; van Gestel AM; van de Putte LB
Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
[TBL] [Abstract][Full Text] [Related]
20. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis.
Taggart AJ; Hill J; Astbury C; Dixon JS; Bird HA; Wright V
Br J Rheumatol; 1987 Feb; 26(1):32-6. PubMed ID: 2880632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]